Stay updated with breaking news from Hennie hoogenboom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Merus (NASDAQ:MRUS – Get Rating) have earned a consensus rating of “Moderate Buy” from the ten ratings firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation and six have issued a buy recommendation on the company. The average 12 month price […] ....
Tekla Capital Management LLC trimmed its position in shares of Merus (NASDAQ:MRUS – Get Rating) by 45.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 92,325 shares of the biotechnology company’s stock after selling 76,882 shares during the period. Tekla Capital […] ....
Shares of Merus (NASDAQ:MRUS – Get Rating) have been given a consensus rating of “Moderate Buy” by the ten analysts that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and seven have assigned a buy recommendation to the company. The average 12 month target price […] ....
Shares of Merus (NASDAQ:MRUS – Get Rating) have earned a consensus rating of “Moderate Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and seven have given a buy recommendation to the company. The average 1 year price target […] ....
Merus (NASDAQ:MRUS – Get Rating) had its target price upped by HC Wainwright from $40.00 to $48.00 in a report issued on Friday, The Fly reports. A number of other analysts also recently commented on the stock. BMO Capital Markets increased their price objective on shares of Merus from $47.00 to $49.00 in a report […] ....